Naloxone Dispensing Information for Pharmacies

Naloxone is a safe medication that can reverse the effects of opioids. Pharmacists who dispense naloxone can play a critical role in reducing the morbidity and mortality associated with opioid overdose in New York City.

The Department of Health has issued a citywide non-patient specific prescription or standing order. This authorizes all pharmacists and supervised pharmacy interns to dispense naloxone to anyone who requests it, without a patient-specific prescription.

Sign Up to Dispense Naloxone

To immediately access a signed copy of the standing order and to enroll your pharmacy in the reporting system, complete the New York City Pharmacy Naloxone Dispensing Agreement.

For more information, email

Requirements for Participating Pharmacies

To dispense naloxone under the standing order, you must:

If you have any questions, email


Standing order prescriber information:

Prescriber: Ashwin Vasan, MD, PhD
NPI: 1225337413
Address: 42-09 28th Street, Long Island City, NY 11101
License: Access the standing order.

Dispense two doses of naloxone and necessary devices for administration. Two naloxone products are currently authorized under the standing order:

  • Single-step Narcan® Nasal Spray. NDC 69547-353-02
  • Multi-step intramuscular naloxone vial and syringe. NDC 0409-1215-01 or NDC 67457-292-02


The following records must be maintained by the pharmacy:

  • Name of the recipient
  • Name of the pharmacist
  • Date on which naloxone is dispensed
  • Number of naloxone units dispensed at each interaction.
    • 1 unit=2 doses naloxone, regardless of formulation

Quarterly dispensing reports must be submitted to the NYC Department of Health with the total number of units dispensed for each naloxone formulation/product.

  • You will be emailed a report reminder with a link for submitting your report by the following dates:
    • April 15 for reporting period January 1 - March 31
    • July 15 for reporting period April 1 - June 30
    • October 15 for reporting period July 1 - September 30
    • January 15 for reporting period October 1 - December 31
  • If your pharmacy is unable to submit reports online, email to discuss an alternative way to submit reports.


Many insurance plans cover naloxone. Consider insurance coverage and patient preference when dispensing.

The Naloxone Co-payment Assistance Program (N-CAP) is a State program that covers up to $40 of a patient’s co-pay for naloxone if they have prescription coverage. To bill under N-CAP, the pharmacy must be enrolled in the New York State AIDS Drug Assistance Program (ADAP).

Patients who cannot afford naloxone and are not eligible to use N-CAP can contact NYC Well for a referral to a free naloxone dispenser.

Additional Resources

More Information